Related Experiment Video
Updated: Jun 27, 2026
08:30
Multiplexed Single Cell mRNA Sequencing Analysis of Mouse Embryonic Cells
Published on: January 7, 2020
Multispecies transcriptome analysis identifies networks protecting against MASLD in Göttingen minipigs
Pascal Gottmann1, Wenke Jonas1, Simone Renner2
1Department of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), Nuthetal, Germany; German Center for Diabetes Research (DZD), Neuherberg, Germany.
Journal of Lipid Research
|June 25, 2026
Summary
Göttingen minipigs resist fatty liver disease due to a unique liver gene expression program. This involves specific transcription factors and secreted proteins, offering potential targets for treating metabolic dysfunction-associated steatotic liver disease.
Area of Science:
- Genomics
- Metabolic disease research
- Comparative transcriptomics
Background:
- Metabolic dysfunction-associated steatotic liver disease (MASLD) poses a significant health burden.
- Göttingen minipigs exhibit a natural resistance to MASLD, making them a valuable model for studying protective mechanisms.
Purpose of the Study:
- To elucidate the molecular mechanisms behind Göttingen minipigs' resistance to MASLD.
- To identify key genes and pathways involved in preventing hepatic steatosis.
Main Methods:
- Multi-level transcriptomic analysis comparing Göttingen minipigs' liver with human, mouse, and susceptible pig breeds.
- Weighted gene co-expression network analysis (WGCNA) to identify core regulatory networks.
Main Results:
- Identified 692 uniquely differentially expressed genes in Göttingen minipigs' livers, associated with metabolic and signaling pathways.
- Discovered 11 transcription factors, 3 hepatokines (DPP4, ITIH1, ITIH3), and 6 secreted proteins (PCSK9, APOM) as potential MASLD resistance mediators.
- Uncovered a core regulatory network driven by HMBOX1 and PATZ1, potentially regulating 41% of differentially expressed genes.
Conclusions:
- A distinct transcriptional program, orchestrated by HMBOX1/PATZ1 and involving specific secreted factors, underlies the MASLD-resistant phenotype in Göttingen minipigs.
- These findings suggest novel therapeutic targets for the prevention and treatment of fatty liver disease.
